Jeff Yass’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55.3K Sell
28,800
-17,000
-37% -$47.9K ﹤0.01% 12847
2026
Q2
$142K Buy
45,800
+8,600
+23% +$28.3K ﹤0.01% 12246
2026
Q1
$100K Sell
37,200
-49,100
-57% -$136K ﹤0.01% 12344
2025
Q4
$189K Buy
86,300
+71,400
+479% +$177K ﹤0.01% 10941
2025
Q3
$34.9K Sell
14,900
-47,200
-76% -$81K ﹤0.01% 11952
2025
Q2
$94.4K Buy
62,100
+4,100
+7% +$6.39K ﹤0.01% 11831
2025
Q1
$80.6K Buy
58,000
+27,400
+90% +$58.4K ﹤0.01% 11670
2024
Q4
$69.5K Sell
30,600
-41,200
-57% -$145K ﹤0.01% 11543
2024
Q3
$339K Buy
71,800
+52,500
+272% +$304K ﹤0.01% 9330
2024
Q2
$144K Sell
19,300
-14,500
-43% -$178K ﹤0.01% 10727
2024
Q1
$577K Buy
33,800
+10,900
+48% +$234K ﹤0.01% 8163
2023
Q4
$520K Sell
22,900
-14,000
-38% -$235K ﹤0.01% 8578
2023
Q3
$562K Buy
36,900
+8,600
+30% +$118K ﹤0.01% 7960
2023
Q2
$365K Buy
+28,300
New +$307K ﹤0.01% 9037
2022
Q2
– Sell
-13,600
Closed -$28K – 12946
2022
Q1
$28K Sell
13,600
-42,300
-76% -$111K ﹤0.01% 12528
2021
Q4
$212K Buy
55,900
+25,100
+81% +$268K ﹤0.01% 11320
2021
Q3
$375K Sell
30,800
-9,200
-23% -$84.8K ﹤0.01% 10077
2021
Q2
$344K Buy
+40,000
New +$393K ﹤0.01% 10476

Other funds holding CABA

Jeff Yass's CABA Position: Q3 2026 in Review

Jeff Yass increased its Cabaletta Bio (CABA) stake by 288% in Q3 2026, buying an estimated $513K and bringing the position to 245,275 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #9902.

Jeff Yass first reported a position in CABA in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.19M in Q1 2023. 159 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Jeff Yass held 245,275 shares of Cabaletta Bio worth $471K as of Q3 2026.
  • Jeff Yass bought 182,047 Cabaletta Bio shares in Q3 2026, an estimated $513K.
  • Cabaletta Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9902 holding.
  • Jeff Yass first reported a position in Cabaletta Bio in Q4 2019 and has held it in 21 quarters since.
  • Jeff Yass's Cabaletta Bio position peaked at $2.19M in Q1 2023.
  • 159 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.